211 related articles for article (PubMed ID: 36167994)
1. [Healthcare networks for people with rare diseases: integrating data and expertise].
Graessner H; Storf H; Schaefer F
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1164-1169. PubMed ID: 36167994
[TBL] [Abstract][Full Text] [Related]
2. [European Reference Networks : Consequences for healthcare in Germany].
Graessner H; Schäfer F; Scarpa M; Wagner TOF
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
[TBL] [Abstract][Full Text] [Related]
3. National registries of rare diseases in Europe: an overview of the current situation and experiences.
Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
[TBL] [Abstract][Full Text] [Related]
4. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
Parker S
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
[TBL] [Abstract][Full Text] [Related]
5. Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders.
Smith M; Alexander E; Marcinkute R; Dan D; Rawson M; Banka S; Gavin J; Mina H; Hennessy C; Riccardi F; Radio FC; Havlovicova M; Cassina M; Emandi AC; Fradin M; Gompertz L; Nordgren A; Traberg R; Rossi M; Trimouille A; Sowmyalakshmi R; Dallapiccola B; Renieri A; Faivre L; Kerr B; Verloes A; Clayton-Smith J; Douzgou S;
Orphanet J Rare Dis; 2020 Apr; 15(1):103. PubMed ID: 32334637
[TBL] [Abstract][Full Text] [Related]
6. [European Reference Network for Rare Hepatological Diseases (ERN RARE-LIVER)].
Schulz L; Sebode M; Schramm C; Lohse AW
Internist (Berl); 2021 Apr; 62(4):441-448. PubMed ID: 33687527
[TBL] [Abstract][Full Text] [Related]
7. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.
Talarico R; Aguilera S; Alexander T; Amoura Z; Andersen J; Arnaud L; Avcin T; Marsal Barril S; Beretta L; Bombardieri S; Bortoluzzi A; Bouillot C; Bulina I; Burmester GR; Cannizzo S; Cavagna L; Chaigne B; Cornet A; Corti P; Costedoat-Chalumeau N; Dāvidsone Z; Doria A; Fenech C; Ferraris A; Fischer-Betz R; Fonseca JE; Frank C; Gaglioti A; Galetti I; Guimarães V; Hachulla E; Holmner M; Houssiau F; Iaccarino L; Jacobsen S; Limper M; Malfait F; Mariette X; Marinello D; Martin T; Matthews L; Matucci-Cerinic M; Meyer A; Milas-Ahić J; Moinzadeh P; Montecucco C; Mouthon L; Müller-Ladner U; Nagy G; Patarata E; Pileckyte M; Pruunsild C; Rednic S; Romão VC; Schneider M; Scirè CA; Smith V; Sulli A; Tamirou F; Tani C; Taruscio D; Taulaigo AV; Tincani A; Ticciati S; Turchetti G; van Hagen PM; van Laar JM; Viera A; de Vries-Bouwstra JK; Zschocke J; Cutolo M; Mosca M
Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):3-11. PubMed ID: 35349419
[TBL] [Abstract][Full Text] [Related]
8. ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions.
Casareto L; Appelman-Dijkstra NM; Brandi ML; Chapurlat R; Cormier-Daire V; Hamdy NAT; Heath KE; Horn J; Mantovani G; Mohnike K; Sousa SB; Travessa A; Wekre LL; Zillikens MC; Sangiorgi L;
Eur J Med Genet; 2024 Apr; 68():104916. PubMed ID: 38296035
[TBL] [Abstract][Full Text] [Related]
9. Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations.
Taruscio D; Gentile AE; Evangelista T; Frazzica RG; Bushby K; Montserrat AM
Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s621-5. PubMed ID: 24922304
[TBL] [Abstract][Full Text] [Related]
10. Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes.
Vos JR; Giepmans L; Röhl C; Geverink N; Hoogerbrugge N;
Fam Cancer; 2019 Apr; 18(2):281-284. PubMed ID: 30302652
[TBL] [Abstract][Full Text] [Related]
11. The Tuscany Regional Network for rare diseases: from European Reference Networks' experience to registry based organisation and management model for rare diseases.
Pieroni F; Marrucci S; Di Pietro L; Berni C; Scaletti C
Orphanet J Rare Dis; 2023 Oct; 18(1):324. PubMed ID: 37833795
[TBL] [Abstract][Full Text] [Related]
12. European Reference networks for rare diseases: what is the conceptual framework?
Héon-Klin V
Orphanet J Rare Dis; 2017 Aug; 12(1):137. PubMed ID: 28784158
[TBL] [Abstract][Full Text] [Related]
13. A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration.
Kinsner-Ovaskainen A; Lanzoni M; Garne E; Loane M; Morris J; Neville A; Nicholl C; Rankin J; Rissmann A; Tucker D; Martin S
Eur J Med Genet; 2018 Sep; 61(9):513-517. PubMed ID: 29597096
[TBL] [Abstract][Full Text] [Related]
14. Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective.
Mañú Pereira MDM; Colombatti R; Alvarez F; Bartolucci P; Bento C; Brunetta AL; Cela E; Christou S; Collado A; de Montalembert M; Dedeken L; Fenaux P; Galacteros F; Glenthøj A; Gutiérrez Valle V; Kattamis A; Kunz J; Lobitz S; McMahon C; Pellegrini M; Reidel S; Russo G; Santos Freire M; van Beers E; Kountouris P; Gulbis B
Lancet Haematol; 2023 Aug; 10(8):e687-e694. PubMed ID: 37451300
[TBL] [Abstract][Full Text] [Related]
15. RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks.
Talarico R; Cannizzo S; Lorenzoni V; Marinello D; Palla I; Pirri S; Ticciati S; Trieste L; Triulzi I; Terol E; Bucher A; Turchetti G
Orphanet J Rare Dis; 2020 Dec; 15(1):347. PubMed ID: 33317578
[TBL] [Abstract][Full Text] [Related]
16. Domain-Specific Common Data Elements for Rare Disease Registration: Conceptual Approach of a European Joint Initiative Toward Semantic Interoperability in Rare Disease Research.
Abaza H; Kadioglu D; Martin S; Papadopoulou A; Dos Santos Vieira B; Schaefer F; Storf H
JMIR Med Inform; 2022 May; 10(5):e32158. PubMed ID: 35594066
[TBL] [Abstract][Full Text] [Related]
17. European expert network on rare communicable diseases and other rare diseases linked to mobility and globalisation focused on health care provision (EURaDMoG): a feasibility study.
Requena-Méndez A; Bisoffi Z; Vives-Corrons JL; Gascon J; Plasència A
Orphanet J Rare Dis; 2020 Oct; 15(1):291. PubMed ID: 33066818
[TBL] [Abstract][Full Text] [Related]
18. Interoperability Architecture for a Paediatric Oncology European Reference Network.
Nitzlnader M; Canete Nieto A; Ribelles AJ; Brunmair B; Ladenstein R; Schreier G
Stud Health Technol Inform; 2016; 223():39-45. PubMed ID: 27139383
[TBL] [Abstract][Full Text] [Related]
19. The European Union Policy in the Field of Rare Diseases.
Moliner AM; Waligora J
Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592
[TBL] [Abstract][Full Text] [Related]
20. Policies and actions to tackle rare diseases at European level.
Montserrat A; Taruscio D
Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
